with your 30b valuation ceiling for early 2022 buyout, you valued post 1 at preclinical and 2.5b. given it has the most potential(as per Dr T.) are we not doing it justice?
although I agree with you that we will probably not get a buyout figure that would potential be equal to the success of 3 pillars, would that mean the ultimate deal would be buyout with royalties? Would this type of deal get the most out of pillar 2/3?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.025(2.11%) |
Mkt cap ! $201.5M | |||
| Open | High | Low | Value | Volume |
| $1.17 | $1.19 | $1.16 | $39.17K | 33.62K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3560 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 4359 | 2 |
View Market Depth
| Last trade - 16.10pm 16/07/2025 (20 minute delay) ? |
| RAC (ASX) Chart |